Estradiol ameliorates arthritis and protects against systemic bone loss in Staphylococcus aureus infection in mice

Arthritis Research and Therapy

Volumn 14, Issue 2, 2012, Pages

  Gjertsson, Inger ^a   Lagerquist, Marie K ^a,b   Kristiansson, Erik ^c   Carlsten, Hans ^a,b   Lindholm, Catharina ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; ESTRADIOL; INTERLEUKIN 10;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL ARTHRITIS; BONE MASS; CYTOKINE RELEASE; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; FEMALE; INOCULATION; MOUSE; NONHUMAN; OSTEOLYSIS; OUTCOME ASSESSMENT; OVARIECTOMY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TRABECULAR BONE; ANIMAL; BONE DENSITY; C57BL MOUSE; INFECTIOUS ARTHRITIS; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ARTHRITIS, INFECTIOUS; BONE DENSITY; BONE RESORPTION; ESTRADIOL; FEMALE; MICE; MICE, INBRED C57BL; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84859704400     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3799     Document Type: Article

References (37)

1. Lipsky BA, Weigelt JA, Gupta V, Killian A, Peng MM. Skin, soft tissue, bone, and joint infections in hospitalized patients: epidemiology and microbiological, clinical, and economic outcomes. Infect Control Hosp Epidemiol 2007, 28:1290-1298. 10.1086/520743, 17926281.
2. Tarkowski A. Infection and musculoskeletal conditions: infectious arthritis. Best Pract Res 2006, 20:1029-1044.
3. Verdrengh M, Carlsten H, Ohlsson C, Tarkowski A. Rapid systemic bone resorption during the course of Staphylococcus aureus-induced arthritis. J Infect Dis 2006, 194:1597-1600. 10.1086/508751, 17083046.
4. Ishimi Y, Miyaura C, Jin CH, Akatsu T, Abe E, Nakamura Y, Yamaguchi A, Yoshiki S, Matsuda T, Hirano T, Kishimoto T, Suda T. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 1990, 145:3297-3303.
5. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 1986, 319:516-518. 10.1038/319516a0, 3511389.
6. Zhao YX, Tarkowski A. Impact of interferon-gamma receptor deficiency on experimental Staphylococcus aureus septicemia and arthritis. J Immunol 1995, 155:5736-5742.
7. Bremell T, Tarkowski A. Preferential induction of septic arthritis and mortality by superantigen-producing staphylococci. Infect Immun 1995, 63:4185-4187. 173591, 7558340.
8. Zhao YX, Ljungdahl A, Olsson T, Tarkowski A. In situ hybridization analysis of synovial and systemic cytokine messenger RNA expression in superantigen-mediated Staphylococcus aureus arthritis. Arthritis Rheum 1996, 39:959-967. 10.1002/art.1780390613, 8651990.
9. Hultgren O, Eugster HP, Sedgwick JD, Korner H, Tarkowski A. TNF/lymphotoxin-alpha double-mutant mice resist septic arthritis but display increased mortality in response to Staphylococcus aureus. J Immunol 1998, 161:5937-5942.
10. Couper KN, Blount DG, Riley EM. IL-10: the master regulator of immunity to infection. J Immunol 2008, 180:5771-5777.
11. Gjertsson I, Hultgren OH, Tarkowski A. Interleukin-10 ameliorates the outcome of Staphylococcus aureus arthritis by promoting bacterial clearance. Clin Exp Immunol 2002, 130:409-414. 10.1046/j.1365-2249.2002.01999.x, 1906560, 12452830.
12. Owens JM, Gallagher AC, Chambers TJ. IL-10 modulates formation of osteoclasts in murine hemopoietic cultures. J Immunol 1996, 157:936-940.
13. Sasaki H, Hou L, Belani A, Wang CY, Uchiyama T, Muller R, Stashenko P. IL-10, but not IL-4, suppresses infection-stimulated bone resorption in vivo. J Immunol 2000, 165:3626-3630.
14. Verdrengh M, Carlsten H, Ohlsson C, Tarkowski A. Addition of bisphosphonate to antibiotic and anti-inflammatory treatment reduces bone resorption in experimental Staphylococcus aureus-induced arthritis. J Orthop Res 2007, 25:304-310. 10.1002/jor.20317, 17089391.
15. Verdrengh M, Bokarewa M, Ohlsson C, Stolina M, Tarkowski A. RANKL-targeted therapy inhibits bone resorption in experimental Staphylococcus aureus-induced arthritis. Bone 2010, 46:752-758. 10.1016/j.bone.2009.10.028, 19879986.
16. D'Elia HF, Larsen A, Mattsson LA, Waltbrand E, Kvist G, Mellstrom D, Saxne T, Ohlsson C, Nordborg E, Carlsten H. Influence of hormone replacement therapy on disease progression and bone mineral density in rheumatoid arthritis. J Rheumatol 2003, 30:1456-1463.
17. Holmdahl R, Jansson L, Andersson M. Female sex hormones suppress development of collagen-induced arthritis in mice. Arthritis Rheum 1986, 29:1501-1509. 10.1002/art.1780291212, 3801072.
18. Jansson L, Holmdahl R. Enhancement of collagen-induced arthritis in female mice by estrogen receptor blockage. Arthritis Rheum 2001, 44:2168-2175. 10.1002/1529-0131(200109)44:9<2168::AID-ART370>3.0.CO;2-2, 11592382.
19. Jochems C, Islander U, Kallkopf A, Lagerquist M, Ohlsson C, Carlsten H. Role of raloxifene as a potent inhibitor of experimental postmenopausal polyarthritis and osteoporosis. Arthritis Rheum 2007, 56:3261-3270. 10.1002/art.22873, 17907171.
20. Engdahl C, Jochems C, Windahl SH, Borjesson AE, Ohlsson C, Carlsten H, Lagerquist MK. Amelioration of collagen-induced arthritis and immune-associated bone loss through signaling via estrogen receptor alpha, and not estrogen receptor beta or G protein-coupled receptor 30. Arthritis Rheum 2010, 62:524-533.
21. Bremell T, Lange S, Svensson L, Jennische E, Grondahl K, Carlsten H, Tarkowski A. Outbreak of spontaneous staphylococcal arthritis and osteitis in mice. Arthritis Rheum 1990, 33:1739-1744. 10.1002/art.1780331120, 2242071.
22. Windahl SH, Vidal O, Andersson G, Gustafsson JA, Ohlsson C. Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(-/-) mice. J Clin Invest 1999, 104:895-901. 10.1172/JCI6730, 408552, 10510330.
23. The R Project for Statistical Computing. , http://www.r-project.org
24. Ostensen M, Aune B, Husby G. Effect of pregnancy and hormonal changes on the activity of rheumatoid arthritis. Scand J Rheumatol 1983, 12:69-72. 10.3109/03009748309102886, 6857175.
25. Sakiniene E, Bremell T, Tarkowski A. Addition of corticosteroids to antibiotic treatment ameliorates the course of experimental Staphylococcus aureus arthritis. Arthritis Rheum 1996, 39:1596-1605. 10.1002/art.1780390921, 8814072.
26. Yang L, Liang J, Yao G, Chen P, Hou Y. 17beta-estradiol regulates the numbers, endocytosis, stimulative capacity and IL-10 secretion of mouse spleen dendritic cells. Toxicol Lett 2005, 155:239-246. 10.1016/j.toxlet.2004.09.016, 15603918.
27. Kanda N, Tamaki K. Estrogen enhances immunoglobulin production by human PBMCs. J Allergy Clin Immunol 1999, 103:282-288. 10.1016/S0091-6749(99)70503-8, 9949320.
28. Polanczyk MJ, Hopke C, Vandenbark AA, Offner H. Estrogen-mediated immunomodulation involves reduced activation of effector T cells, potentiation of Treg cells, and enhanced expression of the PD-1 costimulatory pathway. J Neurosci Res 2006, 84:370-378. 10.1002/jnr.20881, 16676326.
29. Hong MH, Williams H, Jin CH, Pike JW. The inhibitory effect of interleukin-10 on mouse osteoclast formation involves novel tyrosine-phosphorylated proteins. J Bone Miner Res 2000, 15:911-918.
30. Park-Min KH, Ji JD, Antoniv T, Reid AC, Silver RB, Humphrey MB, Nakamura M, Ivashkiv LB. IL-10 suppresses calcium-mediated costimulation of receptor activator NF-kappa B signaling during human osteoclast differentiation by inhibiting TREM-2 expression. J Immunol 2009, 183:2444-2455. 10.4049/jimmunol.0804165, 2742169, 19625651.
31. Luo CY, Wang L, Sun C, Li DJ. Estrogen enhances the functions of CD4(+)CD25(+)Foxp3(+) regulatory T cells that suppress osteoclast differentiation and bone resorption in vitro. Cell Mol Immunol 2011, 8:50-58.
32. Santora K, Rasa C, Visco D, Steinetz BG, Bagnell CA. Antiarthritic effects of relaxin, in combination with estrogen, in rat adjuvant-induced arthritis. J Pharmacol Exp Ther 2007, 322:887-893. 10.1124/jpet.107.122903, 17526806.
33. Marriott I, Huet-Hudson YM. Sexual dimorphism in innate immune responses to infectious organisms. Immunol Res 2006, 34:177-192. 10.1385/IR:34:3:177, 16891670.
34. Meghji S, Crean SJ, Hill PA, Sheikh M, Nair SP, Heron K, Henderson B, Mawer EB, Harris M. Surface-associated protein from Staphylococcus aureus stimulates osteoclastogenesis: possible role in S. aureus-induced bone pathology. Br J Rheumatol 1998, 37:1095-1101. 10.1093/rheumatology/37.10.1095, 9825749.
35. Somayaji SN, Ritchie S, Sahraei M, Marriott I, Hudson MC. Staphylococcus aureus induces expression of receptor activator of NF-kappaB ligand and prostaglandin E2 in infected murine osteoblasts. Infect Immun 2008, 76:5120-5126. 10.1128/IAI.00228-08, 2573315, 18765718.
36. Sinigaglia L, Varenna M, Girasole G, Bianchi G. Epidemiology of osteoporosis in rheumatic diseases. Rheum Dis Clin North Am 2006, 32:631-658. 10.1016/j.rdc.2006.07.002, 17288969.
37. Forsblad D'Elia H, Larsen A, Waltbrand E, Kvist G, Mellstrom D, Saxne T, Ohlsson C, Nordborg E, Carlsten H. Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis. Ann Rheum Dis 2003, 62:617-623. 10.1136/ard.62.7.617, 1754591, 12810422.